VSee Health, Inc. Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current
VSee Health, Inc. (VSEE) had Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current of $135.00 thousand as of 2023-12-31, per its 10-K/A filed 2025-08-29.
Financial Statements › Notes › Other Liabilities
us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent · last filed 2026-03-31
- 2023-12-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $135.00K.
- 2023-08-01: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $135.00K.
| Period end | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current |
|---|---|
| 2023-12-31 | $135.00K 10-K/A · filed 2025-08-29 |
| 2023-08-01 | $135.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |